Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury

International Journal of Impotence Research

Volumn 15, Issue 6, 2003, Pages 405-411

  Ahn, B O ^a,b   Kang, K K ^b   Ahn, G J ^b   Kwon, J W ^b   Kim, W B ^b   Kang, K S ^a   Lee, Y S ^a  

^a Seoul National University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

Author keywords

DA 8159; Penile erection; Phosphodiesterase inhibitor; Rabbit; Spinal cord injury

Indexed keywords

NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; UDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ERECTILE DYSFUNCTION; HISTOPATHOLOGY; LUMBAR VERTEBRA; MALE; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SEXUAL AROUSAL; SPASTIC PARAPLEGIA; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; SPINAL CORD TRANSSECTION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ACUTE DISEASE; ANIMALS; AREA UNDER CURVE; DISEASE MODELS, ANIMAL; IMPOTENCE; MALE; PENILE ERECTION; PYRIMIDINES; RABBITS; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0345872271     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901055     Document Type: Article

References (38)

1. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995; 75: 191-236.
2. Burnett AL et al. Nitric oxicde: a physiologic mediator of penile erection. Science 1992; 257: 401-405.
3. Ignarro LJ et al. Nitric oxide and cyclic GMP formation upon electrical stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170: 843-850.
4. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991; 88: 112-118.
5. Azadzoi KM et al. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone. J Urol 1992; 147: 220-225.
6. Trigo-Rocha F et al. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic noncholinergic neurotransmission in canine penile erection. J Urol 1993; 149: 872-877.
7. Lugg JA, Gonzales-Cadaved NF, Rajfer J. The role of nitric oxide in erectile function. J Androl 1995; 16: 2-4.
8. Burnett AL. Nitric oxide in the penis; physiology and pathology. J Urol 1997; 157: 320-324.
9. Beavo JL. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-748.
10. Ballard SA et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 59:2164-2171.
11. Junemann KP, Buhrle CP, Persson-Junemann C. Pathophysiology of neurogenic impotence. Sex Disabil 1994; 12: 5-15.
12. Aloni R et al. Non-invasive treatment for erectile dysfunction in the neurologically disabled population. J Sex Marital Ther 1992; 18: 243-249.
13. Bodner DR, Haas CA, Krueger B, Seftel AD. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology 1999; 53: 199-202.
14. Lloyd LK, Richards JS. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury. Paraplesia 1989; 27: 457-464.
15. Sanchez RA et al. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord 2001; 39:637-643.
16. Gans WH et al. Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury. J Spinal Cord Med 2001; 24: 35-40.
17. Schmid DM, Schurch B, Hauri D. Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients. Eur Urol 2000; 38: 184-193.
18. Maytom MC et al. A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 1999; 37: 110-116.
19. Oh TY et al. Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res 2000; 23: 471-476.
20. Doh H et al. Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res 2002;25:873-878.
21. Tetik O et al. An intraaortic solution trial to prevent spinal cord injury in a rabbit model. Eur J Vasc Endovasc Surg 2001; 22: 175-179.
22. 2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord. Ann Thorac Surg 2001; 72: 1245-1250.
23. Parrino PE et al. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion. Ann Thorac Surg 1999; 67: 1589-1595.
24. Agee JM et al. Reducing postischemic paraplesia using conjugated superoxide dismutase. Ann Thorac Surg 1991; 51: 911-915.
25. Herold JA et al. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine. J Thorac Cardiovasc Surg 1994; 107: 536-542.
26. Okita Y et al. Repair of aneurysm of the entire descending thoracic aorta or thoracoabdominal aorta using a deep hypothermia. Eur J Cardio-thorac Surg 1997; 12: 120-126.
27. Simpson JI et al. Intrathecal magnesium sulfate protects the spinal cord from ischemic injury thoracic aortic cross-clamping. Anesthesiology 1994; 81: 1493-1499.
28. Comarr AE. Sexuality and fertility among spinal cord and/or cauda equine injuries. J Am Paraplesia Soc 1985; 8: 67-75.
29. Sonda LP, Mazo R, Chancellor MB. The role of yohimbine for the treatment of erectile impotence. J Sex Marital Therap 1990; 16: 15-21.
30. Rivas DA et al. Erectile response to topical, intrurethral and intracorporal pharmacotherapy in a rat model of spinal cord injury. J Spinal Cord Med 1995; 18: 145-150.
31. Aydin S et al. Effects of sildenafil citrate, acethylcholine, and sodium nitroprusside on the relaxation of rabbit cavernosal tissue in vitro. Urology 2001; 58: 119-124.
32. Brown JH, Taylor P. Muscarinic receptor agonists and antagonist. In: Hardman JC et al (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill professional, New York, 1995, pp 141-160.
33. Giuliano F et al. Sildenafil citrate (VIAGRA): a novel oral treatment for erectile dysfunction caused by traumatic spinal cord injury. Int J Clin Pract Suppl 1999; 102: 24-26.
34. Hall ED, Wolf DL. Pharmacological analysis of the pathophysiological mechanism of post-traumatic spinal cord ischemia. J Neurosurg 1986; 64: 951-961.
35. Hall ED, Wolf DL. Neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992; 76: 13-22.
36. Rahman A et al. Neuroprotective effect of regional carnitine on spinal cord ischemia-reperfusion injury. Eur J Cardiothorac Surg 2001; 20: 65-70.
37. Tai C, Booth AM, de Groat WC, Roppolo JR. Penile erection produced by microstimulation of the sacral spinal cord of the cat. IEEE Trans Rehabil Eng 1998; 6: 374-381.
38. Mautes AEM, Weinzierl MR, Donaran F, Noble LJ. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000; 80: 673-687.